Translational Science

The development of a CMV vaccine has been 50 years in the making.

Why are compounds still failing at the final hurdle?

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

Can bacterial viruses improve drug delivery to the brain?

Some have dismissed excitement about the microbiome as “hype,” but real results are beginning to be seen.

Oncology research has come a long way over the past 30 years, but we must transform outdated practices to further improve drug discovery innovation.

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

A new vaccine could help give people at risk of HIV more options.

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.